Grand Brilliance Group Holdings Ltd is an investment holding company primarily engaged in the supply of medical devices. The Company also provides medical device solutions, including market trend analysis, medical device procurement, after-sales service, technical support and training, medical device rental services, and quality assurance. The Company primarily sells medical device products, including medical consumables, medical equipment, and medical devices. In addition, the Company also offers repair services and medical device rental services.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
03/26/03	HK$0.1450	0.00%	0
02/26/02	HK$0.1450	-0.68%	60,000
01/26/01	HK$0.1460	0.00%	0
31/26/31	HK$0.1460	0.00%	0
28/26/28	HK$0.1460	+2.10%	5,50,000

Delayed Quote Hong Kong S.E.

More quotes

Market Closed - Hong Kong S.E. 01:38:20 03/09/2026 pm IST			5-day change	1st Jan Change
0.1450 ^HKD	0.00%		+1.40%	+10.69%

26/06	Grand Brilliance Group Holdings Limited Announces Interim Ordinary Cash Dividend for the Financial Year End 31 March 2026, Payable on August 10, 2026	CI
26/06	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2026	CI

Market Cap	12Cr 1.48Cr 1.28Cr 1.2Cr 1.1Cr 2.05Cr 139.73Cr 2.06Cr 14Cr 5.52Cr 71Cr 5.55Cr 5.43Cr 234.68Cr	P/E 2025	9.13x	P/E 2026	12.5x
Enterprise Value	6.06Cr 77.34L 66.72L 62.85L 57.26L 1.07Cr 73Cr 1.08Cr 7.44Cr 2.89Cr 37Cr 2.9Cr 2.84Cr 122.7Cr	EV / Sales 2025	0.25x	EV / Sales 2026	0.49x
Free-Float	26.97%	Yield 2025	2.31%	Yield 2026	1.91%

26/06	Grand Brilliance Group Holdings Limited Announces Interim Ordinary Cash Dividend for the Financial Year End 31 March 2026, Payable on August 10, 2026	CI
26/06	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2026	CI
21/11	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2025	CI
21/25/21	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2025	CI
21/25/21	Grand Brilliance Group Holdings Limited Announces Interim Dividend for the Financial Year End 31 March 2025, Payable on August 11, 2025	CI
27/25/27	Grand Brilliance Group Holdings Limited Announces Board and Committee Changes, Effective 1 June 2025	CI
14/25/14	Grand Brilliance Group Holdings Limited Announces Resignation of Mr. Mui Wai Sum as Independent Non-Executive Director and Chairman and Member of the Audit Committee and Member of Remuneration Committee	CI
08/24/08	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2024	CI
28/24/28	Grand Brilliance Group Holdings Limited Declares Interim Dividend for the Year Ended 31 March 2024, Payable on or Before 12 August 2024	CI
28/24/28	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Full Year Ended March 31, 2024	CI
13/23/13	Grand Brilliance Group Holdings Limited Reports Earnings Results for the Half Year Ended September 30, 2023	CI
15/23/15	Grand Brilliance Group Holdings Limited Announces Board Changes, Effective September 18, 2023	CI
11/23/11	Grand Brilliance Group Holdings Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	CI

1 week	+1.40%
Current month	-0.68%
1 month	+14.17%
3 months	+2.11%
6 months	+7.41%
Current year	+10.69%

Grand Brilliance Group Holdings Limited Share Price

Stocks

8372

KYG4136R1020

Medical Equipment, Supplies & Distribution

Valuation : Grand Brilliance Group Holdings Limited

Chart: Grand Brilliance Group Holdings Limited

Latest news : Grand Brilliance Group Holdings Limited

Quotes and Performance

Price Extremes

Managers and Directors : Grand Brilliance Group Holdings Limited

Medical Equipment Wholesale

Financials

Company Profile

Quotes

1 week	0.14	0.15
1 month	0.13	0.15
Current year	0.12	0.18
1 year	0.1	0.18
3 years	0.07	0.18
5 years	0.06	0.18
10 years	0.06	0.57

Manager	Title	Age	Since
Bik Kwan Wong CEO	Chief Executive Officer	57	01/03/2018
Chong Chi Cheung DFI	Director of Finance/CFO	48	-
Ka Man Lee SEC	Corporate Secretary	52	24/09/2019

Director	Title	Age	Since
Bik Kwan Wong CHM	Chairman	57	01/03/2018
Yin Shun Miu BRD	Director/Board Member	59	18/09/2017
Man Wai Chiu BRD	Director/Board Member	57	18/09/2017

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
GRAND BRILLIANCE GROUP HOLDINGS LIMITED	0.00%	+1.40%	+21.85%	+101.39%	1.48Cr
HENRY SCHEIN, INC.	+2.11%	+0.01%	+32.17%	+18.39%	1.01TCr
SHIP HEALTHCARE HOLDINGS, INC.	+0.44%	+1.70%	+6.54%	-2.51%	137.26Cr
SHANGHAI C&D INNOSTIC MEDICAL TECHNOLOGY GROUP CO., LTD.	-1.77%	-2.04%	-	-	132.39Cr
AS ONE CORPORATION	+0.84%	+1.58%	-2.50%	-13.64%	111.88Cr
COWEALTH MEDICAL CHINA CO.,LTD.	-1.37%	+2.52%	+81.28%	+42.03%	72Cr
GKHT MEDICAL TECHNOLOGY CO., LTD.	-0.68%	-1.57%	-22.56%	-56.01%	61Cr
EXCELSIOR MEDICAL CO., LTD.	+0.14%	-0.42%	-14.36%	-12.10%	42Cr
NIPPON CARE SUPPLY CO., LTD.	-0.93%	-1.05%	+90.58%	+151.48%	42Cr
WIN-PARTNERS CO., LTD.	+0.72%	-0.86%	-4.90%	+13.90%	22Cr
Average	-0.05%	-0.88%	+20.90%	+26.99%	162.97Cr
Weighted average by Cap.	+1.16%	-0.47%	+27.15%	+15.08%

	2025	2026
Net sales	9.44Cr 1.2Cr 1.04Cr 97.88L 89.18L 1.67Cr 113.77Cr 1.68Cr 12Cr 4.5Cr 58Cr 4.52Cr 4.42Cr 191.08Cr	10Cr 1.28Cr 1.11Cr 1.04Cr 95.09L 1.78Cr 121.32Cr 1.79Cr 12Cr 4.8Cr 62Cr 4.82Cr 4.72Cr 203.75Cr
Net income	94.6L 12.06L 10.41L 10L 9L 16.7L 11Cr 16.82L 1.16Cr 45.04L 5.83Cr 45.3L 44.31L 19Cr	84.13L 10.73L 9L 9L 8L 14.85L 10Cr 14.96L 1.03Cr 40.06L 5.18Cr 40.28L 39.4L 17Cr
Net Debt	-6.24Cr -79.53L -68.61L -64.63L -58.89L -1.1Cr -75Cr -1.11Cr -7.65Cr -2.97Cr -38Cr -2.99Cr -2.92Cr -126.17Cr	-5.54Cr -70.58L -60.89L -57.36L -52.26L -97.69L -67Cr -98.42L -6.79Cr -2.64Cr -34Cr -2.65Cr -2.59Cr -111.98Cr